Skip to main content
Clinical Trials/NCT06006780
NCT06006780
Completed
Not Applicable

Porcine Acellular Dermal Matrix for the Treatment of Localized Gingival Recessions: A Multicenter Randomized Clinical Trial

University of Campinas, Brazil1 site in 1 country40 target enrollmentSeptember 10, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gingival Recession
Sponsor
University of Campinas, Brazil
Enrollment
40
Locations
1
Primary Endpoint
Recession change
Status
Completed
Last Updated
last year

Overview

Brief Summary

Aim: The aim of this randomized clinical trial is to evaluate the use of the porcine acellular dermal matrix (PADM) for the treatment of RT1 localized gingival recessions.

Material and methods: Forthy patients (n=20) with RT1 localized gingival recessions with height ranging from 3 to 5 mm with and at least, 2mm of keratinized tissue width will be selected to participate in the study. Patients will be allocated randomly in two treatment groups: Coronally advanced flap (CAF) or coronally advanced flap associated with the porcine acellular dermal matrix (CAF+ PADM). The clinical parameters evaluated at the baseline, 6 and 12 months will be: Plaque index (IPL); gingival index (GI); relative gingival recession height (RGRH); gingival recession width (GRW); probing depth (PD); relative clinical attachment level (RCAL); keratinized tissue height (KTH); keratinized tissue thickness (KTT); papilla height (PH). Evaluations will be made by the professional and the patient regarding dentin hypersensitivity (HD) (Schiff and VAS scales respectively), aesthetics (RES and VAS scales, respectively) and patient's centered outcomes, through the questionnaire referring to the OHIP-14.

Descriptive statistical analysis will be expressed as mean ± standard deviation (SD), median, quartiles, percentages and confidence intervals (95% CI). To analyze the normality of the residue, the Shapiro-Wilk test will be performed. Then, the Wilcoxon test will be applied to compare the periodontal parameters and a quality of life, before and post-treatment. Correlations between parameters and dental hypersensitivity will be analyzed through Spearman's test. Key words: Gingival recession, Root coverage, Biomaterial, Acellular dermal matrix.

Registry
clinicaltrials.gov
Start Date
September 10, 2022
End Date
December 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Campinas, Brazil
Responsible Party
Principal Investigator
Principal Investigator

Enilson Antonio Sallum

PhD, Chair of Periodontolgy Area

University of Campinas, Brazil

Eligibility Criteria

Inclusion Criteria

  • RT1 localized gingival recessions with height ranging from 3 to 5 mm;
  • 2mm or more of keratinized tissue width ;
  • Probing depth less than 3mm;
  • Plaque and gingival index less or equal to 20%.

Exclusion Criteria

  • Pregnants;
  • Patients with diabetes mellitus or another condition that interfere in the tissue repair
  • Patients who use drugs or medications that interfere in the tissue repair;
  • Allergies to any composition of the devices of the study.

Outcomes

Primary Outcomes

Recession change

Time Frame: Baseline, 6 months and 12 months

Change of the gingival recession height

Secondary Outcomes

  • Thickness of keratinized tissue(Baseline, 6 months and 12 months)

Study Sites (1)

Loading locations...

Similar Trials